VC
IDXX icon

Vicus Capital’s Idexx Laboratories IDXX Stock Holding History

Vicus Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-300
Closed -$203K – 263
2025
Q4 		$203K Buy
+300
New +$204K 0.02% 256
2024
Q2 		– Sell
-389
Closed -$210K – 290
2024
Q1 		$210K Buy
+389
New +$213K 0.02% 259
2023
Q2 		– Sell
-495
Closed -$248K – 216
2023
Q1 		$248K Buy
+495
New +$237K 0.03% 181
2022
Q1 		– Sell
-417
Closed -$221K – 234
2021
Q4 		$221K Buy
+417
New +$262K 0.02% 210
2021
Q2 		– Sell
-409
Closed -$200K – 194
2021
Q1 		$200K Hold
409
– – 0.02% 229
2020
Q4 		$204K Buy
+409
New +$183K 0.03% 221

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vicus Capital's IDXX Position: Q1 2026 in Review

Vicus Capital sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 300 shares — an estimated $203K sold.

Vicus Capital first reported a position in IDXX in Q4 2020 and held it in 6 quarters. The position peaked at $248K in Q1 2023. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Vicus Capital reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Vicus Capital sold 300 Idexx Laboratories shares in Q1 2026, an estimated $203K.
  • Vicus Capital first reported a position in Idexx Laboratories in Q4 2020 and held it in 6 quarters.
  • Vicus Capital's Idexx Laboratories position peaked at $248K in Q1 2023.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.